ProfileGDS4132 / 227013_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 87% 88% 86% 85% 92% 87% 82% 94% 89% 84% 92% 91% 91% 93% 91% 89% 89% 90% 90% 90% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101351.57187
GSM201543Muscle PCOS pioglitazone 121348.89188
GSM201544Muscle PCOS pioglitazone 161370.41486
GSM201545Muscle PCOS pioglitazone 201365.92785
GSM201829Muscle PCOS pioglitazone 231503.45392
GSM201830Muscle PCOS pioglitazon 251352.12887
GSM201831Muscle PCOS pioglitazone 271303.08482
GSM201832Muscle PCOS pioglitazone 31598.44794
GSM201833Muscle PCOS pioglitazone 41404.56389
GSM201834Muscle PCOS pioglitazone 81328.07984
GSM201835Muscle PCOS after pioglitazone 102555.13892
GSM201836Muscle PCOS after pioglitazone 122489.03491
GSM201837Muscle PCOS after pioglitazone 162492.79791
GSM201838Muscle PCOS after pioglitazone 202622.86893
GSM201839Muscle PCOS after pioglitazone 232476.8491
GSM201840Muscle PCOS after pioglitazone 252440.57689
GSM201841Muscle PCOS after pioglitazone 272404.9389
GSM201842Muscle PCOS after pioglitazone 32448.790
GSM201843Muscle PCOS after pioglitazone 42446.38490
GSM201844Muscle PCOS after pioglitazone 82451.89990